3 news items
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
HRTX
29 May 24
on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
HRTX
24 Apr 24
the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
HRTX
11 Apr 24
on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented
- Prev
- 1
- Next